Clinical trial
Levofloxacin, Chronic Bacterial Prostatitis
NCT00277511 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00277511 |
|---|---|
| Title | Levofloxacin, Chronic Bacterial Prostatitis |
| Official title | Prospective, Multinational, Multicenter, Non-Comparative, Open Study With a 6 Months Follow-up Period to Demonstrate the Efficacy and Safety of Oral Levofloxacin 500 mg Once Daily in the Treatment of Chronic Bacterial Prostatitis (CBP) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatitis |
| Intervention type | Drug |
| Interventions | Levofloxacin |
| Enrollment | 120 |
| Start date | Mar 1, 2003 |
| First posted | Jan 16, 2006 |
| Last update posted | Oct 12, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: